• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

LIRAGLUTIDE

Diabetes drugs for Alzheimer’s disease

September 5, 2018Metabolic Disorders, Nervous System Disorders, Vizit Graphs
Diabetes drugs for Alzheimer’s disease

Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s.

Vizit Graphs Tag Cloud

IFNG CANDIDA ALBICANS ESCHERICHIA COLI IL17A AUTOPHAGY CTLA4 CD4 STAPHYLOCOCCUS AUREUS ERBB-2 TNF SOD1 CASP3 INFLAMMATION DIABETES MELLITUS 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CELL PROLIFERATION IMMUNE RESPONSE DOXORUBICIN LISTERIA MONOCYTOGENES NEURODEGENERATIVE DISORDERS RECEPTOR PORPHYROMONAS GINGIVALIS INSULIN HELICOBACTER PYLORI PARKINSON DISEASE STREPTOCOCCUS PNEUMONIAE APOPTOTIC PROCESS BREAST CANCER ANGIOGENESIS IL6 FOXP3 CANCER CLOSTRIDIUM DIFFICILE PSEUDOMONAS AERUGINOSA CELL DEATH RHEUMATOID ARTHRITIS CELL DIVISION CELL DIFFERENTIATION ALZHEIMER'S DISEASE METFORMIN IL23A AGING TH17 CELLS REMICADE TP53

© 2019 Biovista Vizit All Rights Reserved.